Urinary CFHR2 as a Biomarker for Early Diagnosis and Disease Progression Prediction in Diabetic Kidney Disease - PubMed CFHR2 has satisfactory potential to be a biomarker for early diagnosis and risk of progression of DKD.

Study reveals key complement proteins, including C3 and FHR-2, are elevated in the urine of Diabetic Kidney Disease (DKD) patients. FHR-2 shows superior diagnostic power for predicting early DKD occurrence and progression . #DKD #complement #CFHR buff.ly/GIsa49s